Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
22-Apr-2026 | 482 | 487.2 | 473 | 476.65 | 4,443 | 2,56,42,365.7 | 28,559 |
23-Apr-2026 | 476 | 477.75 | 469.55 | 472.2 | 4,764 | 2,67,65,895.75 | 23,835 |
24-Apr-2026 | 470.8 | 477.95 | 463.25 | 467.1 | 3,936 | 1,85,83,939.9 | 18,126 |
27-Apr-2026 | 467.1 | 480 | 463 | 476.5 | 8,595 | 5,23,33,673.4 | 52,476 |
28-Apr-2026 | 478.85 | 485.9 | 474.5 | 480.85 | 4,356 | 3,12,19,841.15 | 34,962 |
29-Apr-2026 | 480.85 | 485.95 | 475 | 478.8 | 5,817 | 3,93,06,761.25 | 40,605 |
30-Apr-2026 | 476 | 481.95 | 470.95 | 476.5 | 6,550 | 3,23,91,956.35 | 36,629 |
04-May-2026 | 472.2 | 494.85 | 472.2 | 492.4 | 11,250 | 17,12,07,416.65 | 2,56,153 |
05-May-2026 | 494.9 | 516.2 | 492.6 | 506.3 | 22,073 | 30,52,58,083.75 | 1,91,477 |
06-May-2026 | 511 | 511.6 | 503.1 | 506.4 | 12,488 | 6,80,65,295.9 | 77,578 |
07-May-2026 | 506.5 | 514.45 | 504.35 | 505.6 | 22,352 | 12,60,16,663.9 | 1,59,242 |
08-May-2026 | 511 | 574.9 | 511 | 549.5 | 2,11,743 | 5,18,71,94,282.95 | 12,79,017 |
11-May-2026 | 549 | 568.9 | 544 | 559.9 | 27,963 | 39,79,92,311.45 | 2,44,405 |
12-May-2026 | 552.5 | 554.2 | 515 | 548.1 | 35,950 | 42,38,52,416.4 | 3,19,892 |
13-May-2026 | 549 | 559.1 | 541.3 | 548 | 14,756 | 16,58,25,460.35 | 1,40,720 |
14-May-2026 | 600 | 600 | 532 | 540.7 | 86,583 | 1,60,33,15,889.25 | 5,11,779 |
15-May-2026 | 534.9 | 549.05 | 522.5 | 528.85 | 15,547 | 21,02,30,581.2 | 1,83,516 |
18-May-2026 | 522.5 | 523 | 505 | 507.4 | 18,395 | 14,51,79,791.85 | 1,20,579 |
19-May-2026 | 506.9 | 513.2 | 504.2 | 508.4 | 12,328 | 8,90,38,012.5 | 83,824 |
20-May-2026 | 507.4 | 520.45 | 495.7 | 518.3 | 18,725 | 15,33,25,397.95 | 1,55,726 |
21-May-2026 | 525.05 | 537.35 | 525.05 | 528.8 | 15,507 | 23,15,09,449.05 | 2,93,962 |
Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years
The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
